VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $203,000 | -43.1% | 2,000 | 0.0% | 0.07% | -41.7% |
| Q3 2015 | $357,000 | -70.5% | 2,000 | -63.3% | 0.12% | -66.6% |
| Q2 2015 | $1,211,000 | +11.9% | 5,450 | 0.0% | 0.36% | +14.0% |
| Q1 2015 | $1,082,000 | -1.3% | 5,450 | -28.9% | 0.32% | -8.4% |
| Q4 2014 | $1,096,000 | +9.1% | 7,660 | 0.0% | 0.34% | +14.7% |
| Q3 2014 | $1,005,000 | -25.8% | 7,660 | -28.6% | 0.30% | -23.9% |
| Q2 2014 | $1,354,000 | -4.3% | 10,735 | 0.0% | 0.39% | -11.1% |
| Q1 2014 | $1,415,000 | +12.3% | 10,735 | 0.0% | 0.44% | +10.8% |
| Q4 2013 | $1,260,000 | +12.5% | 10,735 | 0.0% | 0.40% | +7.2% |
| Q3 2013 | $1,120,000 | +21.2% | 10,735 | 0.0% | 0.37% | +15.5% |
| Q2 2013 | $924,000 | – | 10,735 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |